Vertex Pharmaceuticals VRTX
Vertex Pharmaceuticals is the 90th largest S&P 500 company by market cap, worth $133 billion. 11 directors have filed with the SEC in the last 12 months (who counts), 2 of them executives. 11 other officers are on file. At 30 Jun 2026, Capital Group was its largest institutional holder, with 20.0% of the company.
- CEO
- Reshma Kewalramani
- Chair
- Jeffrey M. Leiden
- Sector
- Health Care
- Sub-industry
- Biotechnology
- Headquarters
- Boston, Massachusetts
- Founded
- 1989
- More
- Wikipedia
- Market cap
- $133B
- 90th largest, 23 Oct 2026 close
- Price to sales
- 11.1
- Market cap over revenue
- Market cap per employee
- $21M
- Market cap over employees
- Connections
- 5
- S&P 500 companies sharing a director or officer
Largest institutional holders
Each fund group's share of Vertex Pharmaceuticals. Where a company has several share classes, the share is of its total value.
13F filings for the quarter to 30 Jun 2026
Board and officers
5 people here also hold roles at other S&P 500 companies.
Roles filed up to 30 Sep 2026
| Name | Title |
|---|---|
| Directors (11) | |
| Jeffrey M. LeidenExecutive ChairmanLast filed 26 Feb 2026 | |
| Reshma KewalramaniCEO & PresidentLast filed 3 Mar 2026 | |
| Sangeeta N. BhatiaDirector | |
| Lloyd CarneyDirectorAlso at Visa | |
| Alan M. GarberDirector | |
| Michel LagardeDirectorAlso at West Pharmaceutical Services | |
| Diana McKenzieDirectorAlso at MetLife | |
| Bruce I. SachsDirector | |
| Jennifer SchneiderDirector | |
| Nancy ThornberryDirector | |
| Suketu UpadhyayDirectorAlso at Incyte | |
| Officers (11) | |
| David AltshulerEVP, Chief Scientific OfficerLast filed 26 Jan 2026 | |
| Kristen AmbroseSVP & Chief Accounting OfficerLast filed 1 Sep 2026 | |
| Edward Morrow Atkinson IIIEVP, Chief Technical Ops. OffLast filed 26 Feb 2026 | |
| Carmen BozicEVP and CMOLast filed 30 Jun 2026 | |
| Mark E. BunnageEVP, Chief Scientific OfficerLast filed 19 May 2026 | |
| Jasper van GrunsvenEVP, CP and NPPOLast filed 10 Sep 2026 | |
| Joy LiuEVP and Chief Legal OfficerLast filed 6 Jul 2026 | |
| Duncan McKechnieEVP, Chief Commercial OfficerLast filed 7 Jul 2026 | |
| Amit SachdevEVP Chief Patient & Ext Af OffLast filed 23 Jul 2026 | |
| Ourania TatsisEVP, Chief Reg. & Quality OffLast filed 23 Jul 2026 | |
| Charles F. Wagner Jr.EVP, Co & FoAlso at TJX CompaniesLast filed 26 Feb 2026 | |
Companies that share people with Vertex Pharmaceuticals
Each person's title here, then at the other company.
- Incyte INCY
- Suketu Upadhyay: Director here, EVP & Chief Financial Officer there
- MetLife MET
- Diana McKenzie: Director here, Director there
- TJX Companies TJX
- Charles F. Wagner Jr.: EVP, Co & Fo here, Director there
- Visa V
- Lloyd Carney: Director here, Director there
- West Pharmaceutical Services WST
- Michel Lagarde: Director here, President and CEO there
Vertex Pharmaceuticals' market cap since December 2008
Marked weeks are changes in the share count, such as a merger, not market moves.
Weekly, up to 23 Oct 2026
| Week ending | Market cap |
|---|---|
| 23 Oct 2026 | $133B |
| 26 Dec 2025 | $118B |
| 27 Dec 2024 | $105B |
| 29 Dec 2023 | $105B |
| 30 Dec 2022 | $74.1B |
| 31 Dec 2021 | $55.8B |
| 25 Dec 2020 | $61.0B |
| 27 Dec 2019 | $56.8B |
| 28 Dec 2018 | $41.3B |
| 29 Dec 2017 | $37.9B |
| 30 Dec 2016 | $18.3B |
| 25 Dec 2015 | $30.7B |
| 26 Dec 2014 | $28.5B |
| 27 Dec 2013 | $17.2B |
| 28 Dec 2012 | $8.9B |
| 30 Dec 2011 | $6.9B |
| 31 Dec 2010 | $7.1B |
| 25 Dec 2009 | $7.7B |
| 26 Dec 2008 | $4.2B |
Download Vertex Pharmaceuticals' data as JSON, with the weekly market caps in billions of dollars from 5 Dec 2008.
Workforce
Headcount at 31 Dec 2025
- Employees
- 6,400
As of December 31, 2025 , we had approximately 6,400 employees.
Insider trades
Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.
Trades from 30 Sep 2025 to 30 Sep 2026
Directors and officers sold $158 million of stock in 59 sales and made no open-market purchases in the 12 months to 30 Sep 2026.
| Date | Person | Value |
|---|---|---|
| 2 Jul 2026Sale | Duncan McKechnieEVP, Chief Commercial Officer | $800K |
| 2 Jul 2026Sale | Ourania TatsisEVP, Chief Reg. & Quality Off | $787K |
| 1 Jul 2026Sale | Joy LiuEVP and Chief Legal Officer | $416K |
| 26 Jun 2026Sale | Carmen BozicEVP and CMO | $288K |
| 18 Jun 2026Sale | Carmen BozicEVP and CMO | $471K |
| 15 Jun 2026Sale | Carmen BozicEVP and CMO | $1.8M |
| 5 Jun 2026Sale | Carmen BozicEVP and CMO | $785K |
| 1 Jun 2026Sale | Joy LiuEVP and Chief Legal Officer | $364K |
| 29 May 2026Sale | Carmen BozicEVP and CMO | $888K |
| 15 May 2026Sale | Carmen BozicEVP and CMO | $614K |
Showing 10 of 59 trades
Trades by members of Congress and officials
Trades members of Congress and senior executive branch officials disclosed, including their families'. Amounts are filed as ranges.
Trades from 20 Oct 2023 to 20 Oct 2026
11 people disclosed 17 purchases and 17 sales of Vertex Pharmaceuticals stock since October 2023.
| Date | Member or official | Amount |
|---|---|---|
| 4 Sep 2026 | Rohit KhannaHouse, D-CA 路 Bought | $1K to $15K |
| 26 Aug 2026 | David J. TaylorHouse, R-OH 路 Sold | $1K to $15K |
| 13 Apr 2026 | Rohit KhannaHouse, D-CA 路 Bought | $1K to $15K |
| 27 Mar 2026 | Alan ArmstrongSenate, R-OK 路 Bought | $1K to $15K |
| 30 Jan 2026 | Arjun ModyDeputy Commissioner 路 Sold | $1K to $15K |
| 29 Jan 2026 | David J. TaylorHouse, R-OH 路 Sold | $1K to $15K |
| 23 Jan 2026 | Rohit KhannaHouse, D-CA 路 Bought | $1K to $15K |
| 7 Oct 2025 | Rohit KhannaHouse, D-CA 路 Bought | $1K to $15K |
| 29 Sep 2025 | Rohit KhannaHouse, D-CA 路 Bought | $1K to $15K |
| 5 Sep 2025 | Rohit KhannaHouse, D-CA 路 Sold | $1K to $15K |
Showing 10 of 34 trades
WARN layoff notices
Notices filed under Vertex Pharmaceuticals' own name. Subsidiaries that file under their own names are not included.
Notices from 26 Oct 2023 to 26 Oct 2026
Vertex Pharmaceuticals filed 1 notice covering 125 workers since October 2023.
| Notice | Place | Workers |
|---|---|---|
| 8 Jun 2025 | Providence, RI | 125 |